Probiotic Effect on Resistin and VEGF serum level in pre-diabetic patients

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190801044405N2

Enrollment

Registered

2021-05-07

Start date

2021-04-09

Completion date

Unknown

Last updated

2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes. Other abnormal glucose

Interventions

Intervention 1: Intervention group: 500mg capsules of Lactocare probiotic for 3 month, 1 capsule daily. Intervention 2: Control group: 500mg placebo capsules for 3 month, 1 capsule daily.

Eligibility

Sex/Gender

All

Age

30 Years to 65 Years

Inclusion criteria

Inclusion criteria: Prediabetic patients Aged 30 to 65 years

Exclusion criteria

Exclusion criteria: Patients with previously diagnosed diabetes treated with hypoglycemic drugs such as metformin Patients with a prior diagnosis of pre-diabetes who are under medication treatment

Design outcomes

Primary

Measure	Time frame
Serum resistin level. Timepoint: Before intervention and after 3 months of medication. Method of measurement: blood test.;Serum level of vegf. Timepoint: Before intervention and after 3 months of medication. Method of measurement: blood test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMina Akbari Rad

Mashhad University of Medical Sciences

akbariradm@mums.ac.ir+98 51 3802 2370

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026